StonvexLoading…
StonvexStonvexStonvexCore line items from NSTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $59.00K | $252.00K | $189.00K | $123.00K |
Operating Income | $-39.00K | $-386.00K | $-521.00K | $-586.00K |
Net Income | $-39.00K | $-386.00K | $-521.00K | $-586.00K |
EPS (Diluted) | $-0.01 | $-0.08 | $-0.11 | $-0.12 |
Total Assets | $270.32M | $266.65M | $269.84M | $275.98M |
Total Liabilities | $190.34M | $186.67M | $190.90M | $198.14M |
Cash & Equivalents | $43.39M | $34.04M | $34.13M | $47.49M |
Free Cash Flow OCF − CapEx | $5.52M | $3.95M | $745.00K | $-2.11M |
Shares Outstanding | 5.26M | 5.26M | 4.88M | 5.24M |